1. Home
  2. Analysis
  3. Ipratropium-bromide
  4. Droperidol

Ipratropium bromide and Droperidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Droperidol (droperidol). Common drug interactions include cardiomyopathy among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Droperidol. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,452 Droperidol users. Check the latest studies of Droperidol.

On Jul, 15, 2026

20 people who take Ipratropium bromide and Droperidol together, and have interactions are studied.

Ipratropium bromide and Droperidol drug interactions.

What are the common drug interactions of Ipratropium Bromide and Droperidol, by gender? *:

female:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Cough
  3. Cytomegalovirus infection
  4. Dyspnoea (difficult or laboured respiration)
  5. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  6. Forced expiratory volume decreased (decreased lung expired air volume)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Haematemesis (vomiting of blood)
  9. Haematocrit decreased
  10. Haemoglobin decreased

male:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Erythema (redness of the skin)
  4. Lethargy (tiredness)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Septicaemia staphylococcal (blood infection with bacteria)
  7. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  8. Bacteraemia (presence of bacteria in the blood)
  9. Blood urea increased
  10. C-reactive protein increased

What are the common drug interactions of Ipratropium Bromide and Droperidol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Cough
  3. Cytomegalovirus infection
  4. Dyspnoea (difficult or laboured respiration)
  5. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  6. Forced expiratory volume decreased (decreased lung expired air volume)
  7. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  8. Night sweats (sweating in night)
  9. Oxygen saturation decreased
  10. Pleural effusion (water on the lungs)

50-59:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Blood urea increased
  3. C-reactive protein increased
  4. Haemoglobin decreased
  5. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  6. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Mucosal inflammation (infection of mucous membrane)
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Rash papular (redness with papule)
  2. Anxiety
  3. Haemoglobin decreased
  4. Injury
  5. International normalised ratio increased
  6. Joint range of motion decreased (disease of joint movement)
  7. Mobility decreased (ability to move is reduced)
  8. Muscle contracture (a permanent shortening of a muscle)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

What are the existing conditions these people have? *

  1. Lung Disorder (lung disease): 5 people, 25.00%
  2. Thrombolysis (resolving the blood clot): 5 people, 25.00%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 25.00%
  4. General Anaesthesia: 5 people, 25.00%
  5. Blood Osmolarity Decreased: 2 people, 10.00%
  6. Electrolyte Imbalance: 2 people, 10.00%
  7. High Blood Pressure: 2 people, 10.00%
  8. Urination - Painful: 2 people, 10.00%
  9. Pain: 2 people, 10.00%
  10. Productive Cough: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Droperidol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ipratropium bromide and Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Droperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and droperidol (the active ingredients of Ipratropium bromide and Droperidol, respectively), and Ipratropium bromide and Droperidol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.